Danel (Adir Yeoshua) Ltd

Danel (Adir Yeoshua) Ltd

DANE.TA
Danel (Adir Yeoshua) LtdIL flagTel Aviv Stock Exchange
46,970.00
ILA
-220.00
- -
2.80BMarket Cap
Danel (Adir Yeoshua) Ltd
DANE.TA
(Tel Aviv Stock Exchange)

Recent

price

46,970.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
135.68
143.99
179.55
210.77
223.61
232.73
257.75
284.63
314.34
326.47
382.81
435.78
439.39
439.79
483.31
504.77
509.87
Revenue per Share
7.22
2.81
8.31
9.82
12.53
11.63
12.09
13.68
14.92
15.39
24.56
33.16
21.52
-1.97
3.59
20.32
22.06
Basic EPS, GAAP
4.3
15.15
10.34
7.33
8.45
8.11
15.05
17.17
13.19
23.08
46.9
34.31
26.33
27.61
32.87
24.01
27.22
Free Cash Flow per Basic Share
3.75
25.09
11.14
6.08
7.94
9.7
11.55
11.07
11.52
12.58
14.28
20.02
19.98
4.49
8.63
14.03
14.73
Dividend per Share
26.44
10.67
- -
3.91
9.06
9.98
9.51
11.3
14.9
16.12
26.92
40.02
41.12
32.21
27.2
33.2
40.82
Book Value per Share
31.38
14.65
- -
-3.45
15.72
17.26
12.56
14.6
33.12
20.1
4.93
18.79
39.31
50.19
49.47
59.84
62.98
Tangible Book Value per Share
4
4
4
4
4
5
5
5
5
5
5
5
5
6
6
6
6
Basic Weighted Avg Shares
533
561
709
861
993
1,082
1,204
1,340
1,493
1,678
1,985
2,289
2,364
2,499
2,759
2,904
2,930
Sales/Revenue/Turnover
4.62
3.96
6.44
6.76
6.72
6.11
6.49
6.51
6.56
6.89
9.38
10.02
7.61
6.9
7.25
7.02
7.24
Operating Margin (%)
4
5
8
12
16
15
16
17
18
62
33
38
39
38
39
40
70
Depreciation Expense
28
11
33
40
56
54
56
64
71
79
127
174
116
-11
21
117
127
Net Income, GAAP
20.09
26.6
26.94
23.84
22.86
22.85
25.13
24.28
24.74
23.85
23.66
22.04
25.12
88.37
58.27
24.92
23.61
Effective Tax Rate (%)
5.32
1.95
4.63
4.66
5.61
5
4.69
4.81
4.75
4.71
6.42
7.61
4.9
-0.45
0.74
4.03
4.33
Profit Margin (%)
45
46
- -
7
67
67
55
54
131
25
36
-2
54
82
142
124
126
Working Capital
38
37
- -
37
35
27
37
26
18
131
146
213
268
296
261
233
229
LT Debt
126
60
- -
51
131
138
116
125
216
266
328
402
508
484
459
515
535
Total Equity
11.16
11.52
60.65
71.23
34.1
28.81
34.03
40.03
36.3
25.44
29.22
30.1
17.87
2.36
9.93
18.41
18.99
Return on Invested Capital (%)
30.74
11.58
73.48
94.72
66.04
65.22
64.96
71.19
76.33
41.3
37.25
38.54
22.71
-1.22
6.43
24.52
24.62
Return on Capital (%)
54.59
15.04
157.95
502.34
198.06
124.85
124.32
131.99
114.34
103.02
114.51
99.58
53.68
-5.55
12.12
67.54
56.88
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
95
94
97
LT Borrowings
42
35
29
LT Finance Leases
206
197
199
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
291,878
271,248
256,093

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
698
681
691
Cash, Cash Equivalents & STI
202
213
215
Accounts Receivable, Net
419
410
424
Inventories
- -
- -
- -
Total Current Liabilities
536
557
565
Payables & Accruals
- -
- -
- -
ST Debt
95
94
97
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.24%
10.26%
12.3%
Free Cash Flow
23%
-8.67%
-26.39%
Net Income, GAAP
18.22%
16.21%
470.24%
Sales/Revenue/Turnover
10.47%
8%
5.26%
Total Cash Common Dividend
17.87%
24.95%
63.97%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
665
689
705
711
2,759
2025
703
715
740
745
2,904
2026
730
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4.34
5.65
6.41
- -
3.59
2025
5.49
4.97
6.01
- -
20.32
2026
7.21
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
2.17
2.92
- -
8.63
2025
0.51
3
5
- -
14.03
2026
0.68
- -
- -
- -
- -
Business
Danel (Adir Yeoshua) Ltd is an Israel-based company primarily engaged in the human resources and healthcare services sectors. The company specializes in providing nursing personnel and professional nursing services through a network of 31 branches across Israel. Its core products and services include nursing services for people under the National Insurance Law, human resource services encompassing recruitment, placement, and employment across various fields such as customer service, office administration, sales and marketing, automobile professions, logistics and supply chain, banking and finance, electricity and electronics, industry, and production. Additionally, Danel operates facilities and services for people with disabilities, including residential mental retardation facilities, hostels for the mentally handicapped and autistic individuals, rehabilitative employment enterprises, and day rehabilitation centers. The company is also involved in the provision and management of medical services including laser eyeglass removal, surgical operations, and in-vitro fertilization through a network of medical centers. Founded in 1974, Danel is headquartered in Ramat Gan, Israel. In recent major developments, Danel acquired a 21.57% stake in AVIV Scientific Ltd. for $22 million in June 2021, reflecting a strategic expansion into scientific and possibly medical-related ventures. The acquisition includes a convertible loan arrangement with potential further investment, signaling the company's strategic investment efforts to diversify and strengthen its service offerings. Danel continues to evolve its human resources and healthcare service activities, maintaining and expanding its presence in Israel's healthcare and employment sectors. Danel targets public and private sector clients needing specialized nursing and human resources, and it operates predominantly within Israel. The company's extensive branch network supports its diversified service portfolio, making it a significant player in the fields of nursing care, human resource services, disability services, and medical services. This comprehensive service offering combined with recent strategic investments positions Danel (Adir Yeoshua) Ltd as a key integrated provider of healthcare and human resource services in the Israeli market, operating under the ticker DANE.TA on the Tel Aviv Stock Exchange. All information reflects the latest publicly available data as of 2025.